Example: Heart Attack

Clinical Trials on Lipid Metabolism, Inborn Errors

Total 709 results





    • NCT02707211
      Unknown status
      Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases
      Conditions: Lipid Metabolism, Inborn Errors
    • NCT00092898
      Completed
      An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)
      Conditions: Lipid Metabolism, Inborn Errors; Heart Disease
    • NCT00092820
      Completed
      Sitosterolemia Extension Study (0653-004)(COMPLETED)
      Conditions: Lipid Metabolism, Inborn Errors; Heart Disease
    • NCT00092807
      Completed
      Sitosterolemia Extension Study (0653-003)(COMPLETED)
      Conditions: Lipid Metabolism, Inborn Errors; Heart Disease
    • NCT00004481
      Completed
      Genetic Study of Sitosterolemia
      Conditions: Lipid Metabolism, Inborn Errors; Sitosterolemia
    • NCT00092833
      Terminated
      Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
      Conditions: Hypercholesterolemia, Familial; Lipid Metabolism, Inborn Errors
    • NCT03198897
      Active, not recruiting
      Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)
      Conditions: Lipoprotein Lipase Deficiency; Inborn Error of Lipid Metabolism; Corneal Arcus
    • NCT01782027
      Suspended
      Mendelian Reverse Cholesterol Transport Study
      Conditions: Cholesterol, HDL; Lipid Metabolism, Inborn Errors; Tangier Disease; LCAT Deficiency; Cholesteryl Ester Transfer Protein (CETP) Deficiency
    • NCT00260299
      Terminated
      Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
      Conditions: Mevalonic Aciduria; Mevalonate Kinase Deficiency; Immune System Diseases; Periodic Fever Syndromes, Hereditary; Lipid Metabolism, Inborn Errors
    • NCT01916512
      Unknown status
      Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia
      Conditions: Low CETP Activity; CETP Deficiency; Hyperalphalipoproteinemia; Hyper-LDL-cholesterolemia; High Level of Remnant Cholesterol
    • NCT03393130
      Unknown status
      Perioperative Research Into Memory, Genomics in the Intensive Therapy Unit: Alzheimer's
      Conditions: Cognitive Impairment; Apolipoprotein E, Deficiency or Defect of; Critical Illness; Burns; Young Adult
    • NCT03531554
      Completed
      Acute Nutritional Ketosis in VLCAD Deficiency
      Conditions: VLCAD Deficiency; Fatty Acid Oxidation Defects
    • NCT01584206
      Completed
      Sitosterolemia Metabolism
      Conditions: Sitosterolemia
    • NCT02635269
      Active, not recruiting
      Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
      Conditions: Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency; Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV); Carnitine Palmitoyl Transferase 2 Deficiency; VLCAD Deficiency; Medium-chain Acyl-CoA Dehydrogenase Deficiency; Multiple Acyl-CoA Dehydrogenase Deficiency; Carnitine Transporter Deficiency; Neutral Lipid Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Glycogen Storage Disease Type V; Muscle Phosphofructokinase Deficiency; Phosphoglucomutase 1 Deficiency; Phosphoglycerate Mutase Deficiency; Phosphoglycerate Kinase Deficiency; Phosphorylase Kinase Deficiency; Beta Enolase Deficiency; Lactate Dehydrogenase Deficiency; Glycogen Synthase Deficiency
    • NCT00694109
      Completed
      An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
      Conditions: Lipid Metabolism, Inborn Errors; Hypercholesterolemia, Autosomal Dominant; Hyperlipidemias; Metabolic Diseases; Hyperlipoproteinemia Type II; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Metabolic Disorder; Congenital Abnormalities; Hypercholesterolemia; Hyperlipoproteinemias; Dyslipidemias; Lipid Metabolism Disorders
    • NCT00607373
      Completed
      Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
      Conditions: Lipid Metabolism, Inborn Errors; Hypercholesterolemia, Autosomal Dominant; Hyperlipidemias; Metabolic Diseases; Hyperlipoproteinemia Type II; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Metabolic Disorder; Congenital Abnormalities; Hypercholesterolemia; Hyperlipoproteinemias; Dyslipidemias; Lipid Metabolism Disorders
    • NCT00477594
      Completed
      Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
      Conditions: Lipid Metabolism, Inborn Errors; Hypercholesterolemia, Autosomal Dominant; Hyperlipidemias; Metabolic Diseases; Hyperlipoproteinemia Type II; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Metabolic Disorder; Congenital Abnormalities; Hypercholesterolemia; Hyperlipoproteinemias; Dyslipidemias; Lipid Metabolism Disorders
    • NCT00362180
      Completed
      Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
      Conditions: Lipid Metabolism, Inborn Errors; Hyperlipidemias; Metabolic Diseases; Hypolipoproteinemia; Hypolipoproteinemias; Hypobetalipoproteinemias; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Congenital Abnormalities; Metabolic Disorder; Hypercholesterolemia; Dyslipidemias; Lipid Metabolism Disorders
    • NCT03384420
      Enrolling by invitation
      A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome
      Conditions: Mitochondrial Diseases; Pearson Syndrome
    • NCT02327364
      Completed
      Natural History of Pearson Syndrome
      Conditions: Pearson Syndrome
    • NCT02104336
      Terminated
      Phase 2 Study of EPI-743 in Children With Pearson Syndrome
      Conditions: Pearson Syndrome
    • NCT03875105
      Not yet recruiting
      Daily Living Activities and Exercise Capacity in Lipid Storage Diseases
      Conditions: Lipid Storage Disease
    • NCT02918032
      Recruiting
      International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
      Conditions: Neutral Lipid Storage Disease
    • NCT01527318
      Completed
      The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
      Conditions: Neutral Lipid Storage Disease
    • NCT02830763
      Terminated
      Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
      Conditions: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV); Neutral Lipid Storage Disease With Myopathy (NLSD-M)
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations